---
run_id: halo-evidence-vs-diagnosis-validation-v9-substrate-workflow-04
created: 2026-05-24
eval_type: contradiction-preservation
case_id: halo-evidence-vs-diagnosis-validation-v9
benchmark_version: halo-evidence-vs-diagnosis-validation-v9-v1
model_condition: substrate_workflow
run_number: 4
model_name: gemma-4-31b-it-mlx
model_id: gemma-4-31b-it-mlx
model_snapshot: LM Studio MLX 8-bit model id lmstudio-community/gemma-4-31B-it-MLX-8bit
runtime: LM Studio local OpenAI-compatible HTTP server; MLX runtime
provider: local
temperature: 0.7
top_p: 0.9
num_ctx: 32768
max_tokens: 1024
seed: 403
prompt_source: condition packet (substrate_workflow) - frozen added material plus frozen Advisor prompt; see run-packet.md
prompt_sha256: 61d771e2bff7fd2e18be1d2999d0f601760656e3e69b4622989ca7bffd3aff8e
source_packet: a substrate preamble plus three reviewed source cards, then the frozen Advisor prompt - see run-packet.md
source_packet_sha256: 8c1fbdb9b2af9238d4533dece4ffc185fda2e1f7ecb6008913243d23d9a67c63
condition_packet_sha256: 8c1fbdb9b2af9238d4533dece4ffc185fda2e1f7ecb6008913243d23d9a67c63
output_file: model-outputs/substrate_workflow-04.md
judge_model_id: pending - judge receipts recorded separately under judge-packet
judge_prompt_sha256: pending - judge receipts recorded separately under judge-packet
judge_independence: pending - judge receipts recorded separately under judge-packet
raw_model_output_public_safe: true
---

# Model Output - substrate_workflow (run 04)

## Condition

Benchmark version `halo-evidence-vs-diagnosis-validation-v9-v1`, condition `substrate_workflow`, run 4 of 8. Real local-model run: `gemma-4-31b-it-mlx` via lmstudio, seed 403, on the frozen condition packet.

## Output

I recommend the **Claim File Review**.

### Rationale
The current evidence for DraftPath's success is heavily contaminated. According to **BK-0048-card-001**, the executive team’s current praise of the product team as "focused" and "disciplined" is likely a result of performance-aware attribution—they are attributing the strong quarter to team traits because they already know the financial outcome.

Furthermore, the financial growth is confounded by "bundle pricing" (a price incentive) and roadmap pitches (a future promise), rather than the current value of the feature. The usage metrics are similarly misleading: high frequency is driven by managers (non-users) and initial curiosity, while front-line adjusters—the primary users—abandon the tool.

Per **BK-0007-card-001**, you need evidence that can "disconfirm the favored story." The Usage Quality Sprint and Commercial Cleanroom measure *activity* and *intent*, but they do not test the "load-bearing diagnosis" (**BK-0001-card-001**) of whether DraftPath actually solves the core problem for adjusters. The Claim File Review is the only option that provides independent causal evidence by auditing the actual work product (the claim files) to see if the software's output is being accepted, rewritten, or ignored.

### The Strongest Reason Against This Recommendation
The Claim File Review is a qualitative, small-sample audit that will not provide the "hard" statistical confidence or immediate revenue forecasting that the board likely desires twelve days before budget lock. It risks being dismissed by the executive team as "anecdotal" compared to the 16% expansion growth and 39% usage spike.

### Observable Evidence That Would Change My Mind
I would pivot to the **Commercial Cleanroom** if you could provide evidence that the "bundle pricing" was a negligible factor in renewals (e.g., if 80% of expansion dollars came from accounts that paid full price). If the financial lift was independent of the discount, the primary uncertainty would shift from "Does the product work?" to "Is the market willing to pay for it?", making the Cleanroom the higher-priority test.
